Bio-Rad Announces Completion of Exchange Offer

Bio-Rad Announces Completion of Exchange Offer 


HERCULES, Calif., Oct. 30  /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc.
(Amex: BIO; BIO.B), a multinational manufacturer and distributor of life science
research products and clinical diagnostics, announced today that it has
completed its offer to exchange $225.0 million aggregate principal amount of its
7.50% Senior Subordinated Notes due 2013 which have been registered under the
Securities Act of 1933, as amended (the "Exchange Notes") for any and all of its
outstanding 7.50% Senior Subordinated Notes due 2013 which were issued in a
private placement (the "Private Notes").  All of the $225.0 million aggregate
principal amount of the Private Notes were tendered and received prior to
expiration of the Exchange.

This announcement is not an offer to exchange, or a solicitation of an offer to
exchange, with respect to the Private Notes. The Exchange Offer was made solely
by the prospectus dated October 1, 2003. 

DATASOURCE: Bio-Rad Laboratories, Inc.



CONTACT:  Christine Tsingos, Vice President and Chief Financial Officer,

or Ron Hutton, Treasurer, [phone], or ,

both of Bio-Rad Laboratories, Inc.



Web site:  http://www.bio-rad.com/ 

Copyright